PRCC and hereditary clear cell renal cell carcinoma: Furthermore, we confirmed that PFK-015 and sunitinib could highly synergistically suppress pRCC cell proliferation, which may provide a promising new treatment strategy for advanced renal cell carcinoma making this combination drug therapy.